Cargando…
Change in (18)F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment
BACKGROUND: Bevacizumab (BEV), a humanized monoclonal antibody, become a currently important chemotherapeutic option for the patients with recurrent glioma. The aim of this retrospective study is to investigate whether (18)F-Fluoromisonidazole (FMISO) PET have the potential to detect BEV-resistant g...
Autores principales: | Yamaguchi, Shigeru, Hirata, Kenji, Toyonaga, Takuya, Kobayashi, Kentaro, Ishi, Yukitomo, Motegi, Hiroaki, Kobayashi, Hiroyuki, Shiga, Tohru, Tamaki, Nagara, Terasaka, Shunsuke, Houkin, Kiyohiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148016/ https://www.ncbi.nlm.nih.gov/pubmed/27936194 http://dx.doi.org/10.1371/journal.pone.0167917 |
Ejemplares similares
-
Clinical Outcome of Cytoreductive Surgery Prior to Bevacizumab for Patients with Recurrent Glioblastoma: A Single-center Retrospective Analysis
por: YAMAGUCHI, Shigeru, et al.
Publicado: (2021) -
ML-04 The influence of surgical intervention for high-dose Methotrexate chemotherapy in the patients with primary central nervous system lymphoma
por: Okamoto, Michinari, et al.
Publicado: (2020) -
Usefulness of FMISO—PET for Glioma Analysis
por: Kobayashi, Hiroyuki, et al.
Publicado: (2013) -
The Roles of Hypoxia Imaging Using (18)F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
por: Hirata, Kenji, et al.
Publicado: (2019) -
Successful Removal of a Metastatic Gastrointestinal Stromal Tumor in the Craniovertebral Junction using an Occipital Artery to Posterior Inferior Cerebellar Artery Bypass
por: Ishi, Yukitomo, et al.
Publicado: (2014)